These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21689774)

  • 21. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for late cytomegalovirus infection after allogeneic stem cell transplantation using HLA-matched sibling donor: donor lymphocyte infusion and previous history of early CMV infection.
    Kim DH; Kim JG; Lee NY; Sung WJ; Sohn SK; Suh JS; Lee KS; Lee KB
    Bone Marrow Transplant; 2004 Jul; 34(1):21-7. PubMed ID: 15133483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus infection in renal transplant recipients: one center's experience.
    Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
    Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cord blood banking and transplant in Europe. Eurocord.
    Gluckman E; Rocha V; Chastang C
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S68-74. PubMed ID: 9715895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-emptive treatment of CMV DNAemia in paediatric stem cell transplantation: the impact of recipient and donor CMV serostatus on the incidence of CMV disease and CMV-related mortality.
    Matthes-Martin S; Lion T; Aberle SW; Fritsch G; Lawitschka A; Bittner B; Frommlet F; Gadner H; Peters C
    Bone Marrow Transplant; 2003 May; 31(9):803-8. PubMed ID: 12732888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation.
    Ganepola S; Gentilini C; Hilbers U; Lange T; Rieger K; Hofmann J; Maier M; Liebert UG; Niederwieser D; Engelmann E; Heilbronn R; Thiel E; Uharek L
    Bone Marrow Transplant; 2007 Mar; 39(5):293-9. PubMed ID: 17262060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor cytomegalovirus seropositivity and the risk of leukemic relapse after reduced-intensity transplants.
    Nachbaur D; Clausen J; Kircher B
    Eur J Haematol; 2006 May; 76(5):414-9. PubMed ID: 16480430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience.
    Piñana JL; Martino R; Barba P; Margall N; Roig MC; Valcárcel D; Sierra J; Rabella N
    Bone Marrow Transplant; 2010 Mar; 45(3):534-42. PubMed ID: 19668235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unrelated cord blood transplants in adults with hematologic malignancies.
    Arcese W; Rocha V; Labopin M; Sanz G; Iori AP; de Lima M; Sirvent A; Busca A; Asano S; Ionescu I; Wernet P; Gluckman E;
    Haematologica; 2006 Feb; 91(2):223-30. PubMed ID: 16461307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early infections in adult patients undergoing unrelated donor cord blood transplantation.
    Saavedra S; Sanz GF; Jarque I; Moscardó F; Jiménez C; Lorenzo I; Martín G; Martínez J; De La Rubia J; Andreu R; Mollá S; Llopis I; Fernández MJ; Salavert M; Acosta B; Gobernado M; Sanz MA
    Bone Marrow Transplant; 2002 Dec; 30(12):937-43. PubMed ID: 12476288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High incidence of cytomegalovirus reactivation in adult recipients of an unrelated cord blood transplant.
    Takami A; Mochizuki K; Asakura H; Yamazaki H; Okumura H; Nakao S
    Haematologica; 2005 Sep; 90(9):1290-2. PubMed ID: 16154862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
    Singh N; Wannstedt C; Keyes L; Wagener MM; Cacciarelli TV
    Liver Transpl; 2005 Jun; 11(6):700-4. PubMed ID: 15915496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.
    Laughlin MJ; Eapen M; Rubinstein P; Wagner JE; Zhang MJ; Champlin RE; Stevens C; Barker JN; Gale RP; Lazarus HM; Marks DI; van Rood JJ; Scaradavou A; Horowitz MM
    N Engl J Med; 2004 Nov; 351(22):2265-75. PubMed ID: 15564543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of donor-recipient cytomegalovirus serology on adult liver transplantation: a single center experience.
    Tryphonopoulos P; Weppler D; Morris MI; Russo C; Nishida S; Levi DM; Moon J; Tekin A; Selvaggi G; Island E; Arosemena L; Ruiz P; Tzakis AG
    Transplantation; 2011 Nov; 92(9):1051-7. PubMed ID: 21876474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.
    Bhutani D; Dyson G; Manasa R; Deol A; Ratanatharathorn V; Ayash L; Abidi M; Lum LG; Al-Kadhimi Z; Uberti JP
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):159-64. PubMed ID: 25445637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of cytomegalovirus infection after pancreas transplantation.
    Parsaik AK; Bhalla T; Dong M; Rostambeigi N; Dierkhising RA; Dean P; Abraham R; Prieto M; Kremers WK; Razonable RR; Kudva YC
    Transplantation; 2011 Nov; 92(9):1044-50. PubMed ID: 21904269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of the source of hematopoietic stem cell in unrelated transplants: comparison between 10/10, 9/10-HLA matched donors and cord blood.
    Granier C; Biard L; Masson E; Porcher R; Peffault de Latour R; Robin M; Boissel N; Xhaard A; Ribaud P; Lengline E; Larghero J; Charron D; Loiseau P; Socié G; Dhédin N
    Am J Hematol; 2015 Oct; 90(10):897-903. PubMed ID: 26149659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk for cytomegalovirus infection following reduced intensity allogeneic stem cell transplantation.
    Nachbaur D; Larcher C; Kircher B; Eibl G; Nussbaumer W; Gunsilius E; Haun M; Grünewald K; Gastl G
    Ann Hematol; 2003 Oct; 82(10):621-7. PubMed ID: 12920570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.